With the global pain-management market projected to surpass $93.9 billion by 2030 and topical analgesics growing at a 7.2% CAGR, CBDL positions itself for major East Coast expansion amid surging consumer demand for natural relief solutions.

SCOTTSDALE, AZ / ACCESS Newswire / November 18, 2025 / CBD Life Sciences Inc. (OTC:CBDL), the parent company of The CBD Vault, proudly announces the official launch of its Tremendous Anti-Inflammatory Soothe Gel, now offered at two premier Red Hots Spa locations in New York:

  • Red Hots Spa - Garden City Hotel
    45 7th Street, Garden City, NY 11530

  • Red Hots Spa - Roslyn, NY
    1500 Old Northern Blvd, Floor 2, Roslyn, NY 11576

This marks a significant East Coast retail expansion for CBDL, aligning the company with one of New York's top luxury spa chains while tapping into the booming nationwide demand for fast-acting natural pain relief.

A Specialized Product Crafted for Red Hots Spa

CBDL's Soothe Gel is a high-performance anti-inflammatory formula engineered for immediate cooling relief and deep tissue penetration - specially curated for the Red Hots Spa clientele, known for premium wellness treatments and high-value customers.

Active Therapeutic Ingredients Include:

  • Menthol - fast-acting cooling relief

  • Camphor - anti-inflammatory & circulation boosting

  • Capsaicin - long-lasting pain desensitization

Targets Relief For:

  • Sprains & muscle stiffness

  • Arthritis & rheumatoid pain

  • Sciatica

  • Fibromyalgia

  • General soreness, inflammation, and chronic pain issues

With millions of Americans seeking non-prescription pain management alternatives each year, CBDL's newest product enters the market at a strategically perfect time.

Major Investor Highlights

  • Expands CBDL's physical retail footprint into two high-traffic luxury spa locations.

  • Places CBDL inside the world-famous Garden City Hotel, one of New York's most prestigious hospitality properties.

  • Targets a fast-growing spa wellness market projected to exceed $150 billion globally by 2030.

  • Enhances CBDL's expanding product catalog and strengthens the company's wholesale division.

  • Deepens CBDL's long-term vision of positioning The CBD Vault as a national leader in natural pain-relief therapeutics.

Management Commentary

"Launching our Soothe Gel inside two Red Hots Spa locations marks a pivotal milestone for CBDL," said Lisa Nelson, President & CEO of CBD Life Sciences Inc.
"These spas cater to high-end customers seeking effective relief solutions, and our product was formulated specifically to meet that demand. We see this partnership as the beginning of a much larger expansion across the East Coast and beyond."

About CBD Life Sciences Inc. (CBDL)

CBD Life Sciences Inc. is a publicly traded company focused on developing and distributing high-quality CBD and wellness products through its flagship brand, The CBD Vault. With an expanding portfolio of therapeutic formulations, the company is aggressively scaling into retail, wholesale, and online sales channels nationwide.

Follow our social media for the latest updates!
X: https://www.x.com/CBDL_StockOTC
Instagram: https://www.instagram.com/cbd.vault
Website: https://www.thecbdvault.com
IR Contact: [email protected]

Stay Connected & Be the First to Try Our New Functional Mushroom Products!

Mushroom Madness Instagram: https://www.instagram.com/mushroom.madnessaz
Mushroom Madness Website: https://www.mushroommadness.shop

Forward-Looking Statements
Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements. Actual results may differ materially from those described in forward-looking statements and are subject to risks and uncertainties. See CBD Life Sciences, Inc's, Inc.'s filings with OTC Markets, which may identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements.

Safe Harbor Statement
This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements.

Contact Information
Lisa Nelson
CEO
[email protected]
4802091720

SOURCE: CBD Life Sciences, Inc.



View the original
on ACCESS Newswire


Information contained on this page is provided by an independent third-party content provider. XPRMedia and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact [email protected]